无代谢异常的肥胖与CKD发病风险:英国队列研究
该回顾性人群队列研究纳入英国THIN数据库444万余名无CKD和心血管病的成人,按BMI与代谢异常组合分11种体型表型,随访5.4年发现无代谢异常的超重和肥胖者CKD发病风险分别升高30%和66%,且随代谢异常数量增加呈梯度升高。
要点
- 无代谢异常的超重和肥胖仍显著增加CKD发病风险。
- 代谢异常数量越多,CKD风险呈梯度升高。
- 65岁以下人群中该关联更强。
核心结论
- 与体重正常且无代谢异常者相比,无代谢异常的超重和肥胖者CKD发病风险更高。
研究设计与样本
- 回顾性人群队列研究,纳入英国THIN数据库1995-2015年444万余名有BMI记录且无CKD和心血管病的成人。
主要发现
- 无代谢异常超重者调整后HR为1.30(95%CI 1.28-1.33),无代谢异常肥胖者调整后HR为1.66(95%CI 1.62-1.70)。
- 该关联在65岁以下人群中更强。
- 所有BMI类别中,代谢异常数量越多,CKD发病风险呈梯度升高。
关键数值与推荐
- CKD定义为记录肾脏替代治疗、CKD诊断、eGFR<60mL/min/1.73m2持续≥90天或尿白蛋白肌酐比>3mg/mmol持续≥90天。
- 11种体型表型由BMI类别(低体重、正常、超重、肥胖)与3种代谢异常(糖尿病、高血压、血脂异常)组合定义。
临床怎么用
- 临床评估CKD风险时不应忽视无代谢异常的超重和肥胖人群。
- 对无代谢异常的超重和肥胖者,尤其是65岁以下者,应关注肾脏风险。
局限性
- 代谢状态可能因延迟诊断而误分类。
- 存在未测量因素的残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Metabolically healthy obesity (obesity without any metabolic abnormality) is not considered to be associated with increased risk of morbidity and mortality. We examined and quantified the association between metabolically healthy overweight/obesity and the risk of incident chronic kidney disease (CKD) in a British primary care population. STUDY DESIGN: Retrospective population-based cohort study. SETTING & PARTICIPANTS: 4,447,955 of the 5,182,908 adults in The Health Improvement Network (THIN) database (United Kingdom, 1995-2015) with a recorded body mass index (BMI) at the time of registration date who were free of CKD and cardiovascular disease. EXPOSURE: 11 body size phenotypes were created, defined by BMI categories (underweight, normal weight, overweight, and obesity) and 3 metabolic abnormalities (diabetes, hypertension, and dyslipidemia). OUTCOME: Incident CKD defined as a recorded code for kidney replacement therapy, a recorded diagnosis of CKD, or by an estimated glomerular filtration rate of<60mL/min/1.73m2 for≥90 days, or a urinary albumin-creatinine ratio>3mg/mmol for≥90 days. RESULTS: Of the 4.5 million individuals, 1,040,921 (23.4%) and 588,909 (13.2%) had metabolically healthy overweight and metabolically healthy obesity, respectively. During a mean follow-up interval of 5.4±4.3 (SD) years, compared with individuals with a metabolically healthy normal weight (n=1,656,231), there was a higher risk of incident CKD among those who had metabolically healthy overweight (adjusted HR, 1.30 [95% CI, 1.28-1.33]) and metabolically healthy obesity (adjusted HR, 1.66 [95% CI, 1.62-1.70]). The association was stronger in those younger than 65 years of age. In all BMI categories, there was greater risk of incident CKD with a greater number of metabolic abnormalities in a graded manner. LIMITATIONS: Potential misclassification of metabolic status due to delayed diagnosis and residual confounding due to unmeasured factors. CONCLUSIONS: Overweight and obesity without metabolic abnormality are associated with a higher risk of incident CKD compared with those with normal body weight and no metabolic abnormality.
引用
- Wang J, Niratharakumar K, Gokhale K, et al. Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study. Am J Kidney Dis. 2021. PMID: 34146618. doi:10.1053/j.ajkd.2021.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。